Jeremy Chadwick , VSP Vision Care
•Download as PPTX, PDF•
0 likes•211 views
How employers can take control of unmanaged chronic disease health costs, and drive productivity across the whole workforce through better eyecare integrated into benefits packages
Report
Share
Report
Share
Recommended
Alphaeon Beauty Eyelash Serum
This document summarizes the key details and results of a clinical study on an eyelash serum produced by ALPHAEON Corporation. The serum is applied to the base of the upper eyelashes daily and conditions and hydrates the lashes, making them appear longer, thicker, and less sparse. After 8 weeks of use, 80% of women in the study agreed their lash appearance improved overall, 76% agreed their lashes looked thicker and more conditioned, and 72% agreed their lashes appeared less sparse.
Ophthalmology Innovation Showcase 2 - ReVision Optics
The document discusses market research data on the presbyopic market in the US and patient outcomes and satisfaction rates for Raindrop vision correction surgery. It finds that there are over 28 million potential patients in the US, with 71% seeking an ophthalmologist for the procedure. Real-world data shows 99% of patients achieving less than 20/20 distance vision and 78% less than J3 near vision, with a low 2.5% explant rate. Surgeon, patient, and reorder satisfaction rates are over 90% based on recent surveys.
Eleven BioTherapeutics
This presentation discusses Eleven Biotherapeutics' development pipeline and upcoming milestones. Eleven is developing two protein therapeutics: Isunakinra, a topical IL-1 receptor blocker in Phase 3 for allergic conjunctivitis, with topline data expected in 1Q16; and EBI-031, a long-acting intravitreal IL-6 antibody planned to enter IND in 1H16 for diabetic macular edema and uveitis. The company highlighted opportunities for these programs to address unmet needs in large ophthalmic markets and provided an overview of upcoming clinical trial timelines and goals.
Why Wellness fails to control medical insurance costs.
The document discusses why wellness programs often fail to control medical costs. It notes that costs always increase due to rising operating expenses and more sickness. While the goal of wellness programs is to stop disease progression and move people backwards in their health status, they often rely on sameness, lack scientific basis, and blame individuals rather than address systemic issues. The document provides examples of ROI from wellness programs at different companies but notes outcomes are often unclear. It concludes that individual choice alone does not impact costs and alternative approaches may be needed.
Electronic Dental Records Adoption
Recently, a study published in the Journal of the American Dental Association shows a growing trend among U.S. dentists to incorporate EDR technology into their practice. Learn about how technology adoption has changed over the last decade among dentists, as well as how they are using the technology in their practices.
Paul Sieving
The National Eye Institute's (NEI) budget for fiscal year 2016 was $695 million, which was used to fund research projects, training, clinical trials, and small business innovation grants. Major initiatives included regenerating neurons and neural connections in the eye through the Audacious Goals Initiative, contributions to the BRAIN Initiative and Precision Medicine Initiative. The NEI supports collaborative research projects, small business grants, and conducts intramural research including stem cell therapy and gene therapy clinical trials. Growing the vision research field through training and diversity programs is also a priority.
An Assessment Of The Advantages and disadvantages Of LASIK Surgery
Picture the miracle of crystal clear vision without the troubles of glasses and contacts via an extr...
ForSight Vision-5
The document discusses an investigational ocular insert called the Helios Insert developed by ForSight VISION5 to treat glaucoma. Clinical trials showed the insert provided clinically significant IOP reduction for 6 months in a safe and comfortable manner. Patients and doctors preferred the insert to eye drops based on market research. ForSight VISION5 believes the insert could address the large problem of non-adherence to eye drops and fulfill an unmet need in the multibillion-dollar glaucoma market. The company is pursuing FDA approval and regulatory clearance for the insert.
Recommended
Alphaeon Beauty Eyelash Serum
This document summarizes the key details and results of a clinical study on an eyelash serum produced by ALPHAEON Corporation. The serum is applied to the base of the upper eyelashes daily and conditions and hydrates the lashes, making them appear longer, thicker, and less sparse. After 8 weeks of use, 80% of women in the study agreed their lash appearance improved overall, 76% agreed their lashes looked thicker and more conditioned, and 72% agreed their lashes appeared less sparse.
Ophthalmology Innovation Showcase 2 - ReVision Optics
The document discusses market research data on the presbyopic market in the US and patient outcomes and satisfaction rates for Raindrop vision correction surgery. It finds that there are over 28 million potential patients in the US, with 71% seeking an ophthalmologist for the procedure. Real-world data shows 99% of patients achieving less than 20/20 distance vision and 78% less than J3 near vision, with a low 2.5% explant rate. Surgeon, patient, and reorder satisfaction rates are over 90% based on recent surveys.
Eleven BioTherapeutics
This presentation discusses Eleven Biotherapeutics' development pipeline and upcoming milestones. Eleven is developing two protein therapeutics: Isunakinra, a topical IL-1 receptor blocker in Phase 3 for allergic conjunctivitis, with topline data expected in 1Q16; and EBI-031, a long-acting intravitreal IL-6 antibody planned to enter IND in 1H16 for diabetic macular edema and uveitis. The company highlighted opportunities for these programs to address unmet needs in large ophthalmic markets and provided an overview of upcoming clinical trial timelines and goals.
Why Wellness fails to control medical insurance costs.
The document discusses why wellness programs often fail to control medical costs. It notes that costs always increase due to rising operating expenses and more sickness. While the goal of wellness programs is to stop disease progression and move people backwards in their health status, they often rely on sameness, lack scientific basis, and blame individuals rather than address systemic issues. The document provides examples of ROI from wellness programs at different companies but notes outcomes are often unclear. It concludes that individual choice alone does not impact costs and alternative approaches may be needed.
Electronic Dental Records Adoption
Recently, a study published in the Journal of the American Dental Association shows a growing trend among U.S. dentists to incorporate EDR technology into their practice. Learn about how technology adoption has changed over the last decade among dentists, as well as how they are using the technology in their practices.
Paul Sieving
The National Eye Institute's (NEI) budget for fiscal year 2016 was $695 million, which was used to fund research projects, training, clinical trials, and small business innovation grants. Major initiatives included regenerating neurons and neural connections in the eye through the Audacious Goals Initiative, contributions to the BRAIN Initiative and Precision Medicine Initiative. The NEI supports collaborative research projects, small business grants, and conducts intramural research including stem cell therapy and gene therapy clinical trials. Growing the vision research field through training and diversity programs is also a priority.
An Assessment Of The Advantages and disadvantages Of LASIK Surgery
Picture the miracle of crystal clear vision without the troubles of glasses and contacts via an extr...
ForSight Vision-5
The document discusses an investigational ocular insert called the Helios Insert developed by ForSight VISION5 to treat glaucoma. Clinical trials showed the insert provided clinically significant IOP reduction for 6 months in a safe and comfortable manner. Patients and doctors preferred the insert to eye drops based on market research. ForSight VISION5 believes the insert could address the large problem of non-adherence to eye drops and fulfill an unmet need in the multibillion-dollar glaucoma market. The company is pursuing FDA approval and regulatory clearance for the insert.
Best practices in alarm management
This webinar covers the real examples of experiences with alarm fatigue and successes in drastically reducing the number of alarms.
SPOTLIGHT ON THE PREMIUM CHANNEL
Presentation from OIS@ASCRS 2016
Moderator:
Elizabeth Yeu, MD
Participants:
David Chang, MD
Eric Donnenfeld, MD
Sherman Reeves, MD, MPH
Denise Visco, MD
Video Presentation:
https://www.youtube.com/watch?v=GTiBOslQYlI&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=37
ForSight Vision-5
ForSight VISION5 is developing an ocular insert system to deliver sustained drug therapy to the eye over 3-6 months for conditions like glaucoma. Their lead product is in Phase 2 trials using a prostaglandin analog to lower intraocular pressure. The insert is designed to eliminate the need for daily eye drops and improve patient compliance. Clinical studies show the insert is well-tolerated and has high retention rates. ForSight VISION5 aims to address the large unmet need of non-compliant glaucoma patients through this novel, non-invasive drug delivery approach.
Ophthalmology Innovation Showcase 1 - Ocular Therapeutix
Ocular Therapeutix is developing sustained-release drug therapies for ophthalmic conditions to improve patient outcomes and compliance. Their lead product, DEXTENZA, is an intracanalicular insert delivering dexamethasone for up to 30 days after cataract surgery to reduce pain and inflammation. Phase 3 trials showed DEXTENZA was well-tolerated and effective in meeting primary efficacy endpoints. If approved, DEXTENZA could become the new standard of care by replacing complex topical drop regimens. The company is also developing sustained-release therapies for glaucoma and posterior segment diseases in collaboration with Regeneron.
Envisia Therapeutics
This document summarizes corporate milestones and pipeline for Envisia Therapeutics, a company developing ophthalmic drug delivery systems. Key points include:
- The company was formed in 2013 and has raised $25 million in funding.
- They are developing long-acting biodegradable formulations of travoprost (ENV515) for glaucoma and difluprednate (ENV905) for post-cataract inflammation. Clinical trials are underway.
- Their PRINT technology platform can produce particles from 100nm to 1000um and is being used to develop extended release formulations of small molecules and biologics for front and back of the eye diseases.
PanOptica
The document summarizes the development of an anti-VEGF eye drop called PAN-90806 being developed by PanOptica for the treatment of wet age-related macular degeneration and other retinal diseases. It describes positive preliminary results from a Phase 1/2 clinical trial in wet AMD patients showing biological activity with no systemic side effects. It also outlines plans to further study PAN-90806 using an advanced formulation in additional clinical trials for wet AMD and proliferative diabetic retinopathy. Developing an effective anti-VEGF eye drop could provide significant benefits over frequent eye injections.
Allegro
Luminate is a drug being developed by Allegro Ophthalmics to treat retinal diseases. It works through a novel anti-integrin mechanism of action compared to existing anti-VEGF drugs. Phase 2 studies showed Luminate had a 65% efficacy rate in resolving vitreomacular traction, a robust safety profile, and durability of at least 3 months in treating diabetic macular edema and wet age-related macular degeneration. Ongoing phase 2b studies are further evaluating Luminate's potential to treat diabetic macular edema, proliferative vitreoretinopathy, and as an alternative to anti-VEGF drugs with longer duration of effect.
Acucela
Acucela is a clinical-stage ophthalmology company that develops novel therapeutics to treat sight-threatening eye diseases. Their lead product candidate, Emixustat hydrochloride, is being studied in clinical trials as a potential treatment for geographic atrophy associated with dry age-related macular degeneration. Preclinical studies showed Emixustat reduced the accumulation of toxins in the retina and protected retinal cells from light damage in a dose-dependent manner. Early clinical trials found Emixustat to be generally safe and well-tolerated, with pharmacologic effects observed in the retina. An ongoing Phase 2b/3 clinical trial is evaluating Emixustat's ability to reduce the growth rate of geographic
AGTC
This presentation discusses AGTC's visionary gene therapy programs to treat ophthalmic diseases. It highlights AGTC's lead product candidates for X-linked Retinoschisis (XLRS), Achromatopsia (ACHM-B3 and A3), and X-linked Retinitis Pigmentosa (XLRP). It also summarizes AGTC's competitive advantages in gene therapy manufacturing and its key upcoming milestones, including filing INDs for ACHM-A3 and XLRP and reporting initial clinical data for XLRS and ACHM-B3 programs in 2016. AGTC aims to become the world leader in ophthalmology gene therapy through its broad pipeline and partnerships.
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
This document provides an overview of a company called Aerie Pharmaceuticals and their glaucoma products. It summarizes results from clinical trials of their two leading investigational drug candidates, Rhopressa and Roclatan. Rhopressa achieved non-inferiority compared to timolol in lowering eye pressure over 6 months in phase 3 trials. A pilot study also found Rhopressa to be effective at lowering pressure during nighttime hours. Roclatan was found to be statistically superior to its individual components, latanoprost and Rhopressa, in lowering pressure at all timepoints in a phase 3 trial. Both drugs demonstrated favorable safety profiles in clinical testing.
Alcon Google Innovation
1) Alcon and Google have partnered to develop "smart lens" technology to address unmet medical needs in eye care, such as treating cataracts, age-related macular degeneration, glaucoma, and presbyopia.
2) The collaboration aims to create glucose-sensing contact lenses to help diabetics manage their condition, and accommodating contact lenses or IOLs to restore near vision for presbyopes.
3) While smart lenses offer advantages like ease of use and data sharing, challenges include ensuring patient privacy as health data is collected and regulatory hurdles in approving new mobile medical devices.
Aerie
Aerie Pharmaceuticals is developing Rhopressa and Roclatan as once-daily eye drops to lower intraocular pressure for glaucoma. Rhopressa demonstrated efficacy in Phase 3 trials and Aerie expects to file an NDA in Q3 2016. Roclatan achieved all endpoints in a Phase 2b trial and is now in Phase 3 trials. Preclinical research also shows Rhopressa may modify diseased tissue and increase blood flow in the eye. Aerie is exploring AR-13154 for wet AMD which showed lesion size reduction exceeding the leading product in studies. The company collaborates with other organizations on delivery technologies and product candidates for the front and back of the eye.
Workplace Health by Dr Jeremy Lim
Dr Jeremy Lim from Oliver Wyman shares key insights on implementing effective workplace health initiatives.
Case Study: SKF Battles Rising Health Care Costs with Walking Program
SKF USA Inc. implemented an integrated wellness program combining biometric screenings and a walking program to improve employee health and reduce rising healthcare costs. Over 80% of employees signed up for the program, which uses pedometers and an online portal to track steps and health goals. Participation remains over 60%, and SKF saw their annual health insurance rate increases drop from 11.3% to just 1.4% after implementing the program. Employees reported feeling healthier, more productive, and more positive about their employer as a result of the wellness initiative. Due to its success, SKF is looking to expand the program to other global entities.
Chris Adams (Ceeable): Augmented Reality to Treat Low Vision Disorders
A talk from the Life Track at AWE USA 2017 - the largest conference for AR+VR in Santa Clara, California May 31- June 2, 2017.
Chris Adams (Ceeable): Augmented Reality to Treat Low Vision Disorders
Ceeable is developing a mobile augmented reality (AR) device to aid people with low vision disorders such as age related macular degeneration (AMD), diabetic retinopathy and retinitis pigmentosum. There are over 280 million people worldwide who have vision disorders and over 15 million in the united states who have AMD. The Ceeable device is based on a commercially available AR hardware platform and incorporates proprietary and patented software algorithms to map and correct for visual distortions in real time. The technology has been demonstrated to be effective in clinical studies and the results have been published in peer review journals. The company envisions the device as the first of many products that will be a significant advancement in technologies to aid low vision patients and demonstrate the capability of AR to change the human condition.
http://AugmentedWorldExpo.com
What to Expect after LASIK
LASIK is an extremely safe and effective procedure that can help you eliminate the need for glasses and contacts. Find out what to expect during your recovery after surgery.
Aerie Pharmaceuticals
Aerie Pharmaceutics "Building a Major Ophthalmic Pharmaceutical Company" Presented at OIS@ASCRS 2015
StatArb Performance
This document summarizes the performance of a statistical arbitrage fund (StatArb1) compared to the S&P 500 index from inception on March 30, 2012 through May 2, 2012. It shows that StatArb1 has lower returns than the S&P 500 since inception and month-to-date, but lower volatility, beta, and maximum drawdown, indicating it may be a less risky investment.
Stat Arb Performance
This document summarizes the performance of a statistical arbitrage strategy compared to the S&P 500 from inception on March 30, 2012 through April 30, 2012. The statistical arbitrage strategy has outperformed the S&P 500 over all time periods shown with lower volatility, beta, and maximum drawdown, though it has a positive correlation to the S&P 500.
Graybug
GrayBug is developing an injectable, long-acting ocular drug delivery technology called GB-102 for treating wet age-related macular degeneration. GB-102 is a dual anti-VEGF/anti-PDGF therapeutic that enables injections every 4-6 months, compared to monthly injections currently required. GrayBug has worldwide rights to the technology from Johns Hopkins University and aims to file an IND for GB-102 in wet AMD in 2016. The company is also exploring applications of its technology for glaucoma and other ocular diseases, with the goal of developing long-acting drugs that improve compliance over daily eye drops.
Medically necessary contacts
This document provides information on medically necessary contact lenses including definitions, benefits, insurance plans, eligibility criteria, billing codes, and examples of how to determine diagnoses and appropriate billing for patients. It discusses criteria for medical necessity including conditions like keratoconus, irregular astigmatism, corneal disorders and transplants, and high ammetropia. Examples are provided of patients' exams and determining appropriate diagnoses and billing codes to use for medical insurance and vision plans. Reimbursement rates for different contact lens types and replacement schedules are also included.
Eye med summary
The document announces that effective January 1, 2013, vision plan benefits for railroad employees will be provided by EyeMed Vision Care instead of VSP. There will be no changes to plan design but some enhancements, including a larger provider network, ID cards for members, and increased discounts. Retirees will have access to a discount plan through EyeMed providers. In November, employees will receive information about the transition to EyeMed, and in January they will receive ID cards and details on their EyeMed benefits and providers.
More Related Content
What's hot
Best practices in alarm management
This webinar covers the real examples of experiences with alarm fatigue and successes in drastically reducing the number of alarms.
SPOTLIGHT ON THE PREMIUM CHANNEL
Presentation from OIS@ASCRS 2016
Moderator:
Elizabeth Yeu, MD
Participants:
David Chang, MD
Eric Donnenfeld, MD
Sherman Reeves, MD, MPH
Denise Visco, MD
Video Presentation:
https://www.youtube.com/watch?v=GTiBOslQYlI&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=37
ForSight Vision-5
ForSight VISION5 is developing an ocular insert system to deliver sustained drug therapy to the eye over 3-6 months for conditions like glaucoma. Their lead product is in Phase 2 trials using a prostaglandin analog to lower intraocular pressure. The insert is designed to eliminate the need for daily eye drops and improve patient compliance. Clinical studies show the insert is well-tolerated and has high retention rates. ForSight VISION5 aims to address the large unmet need of non-compliant glaucoma patients through this novel, non-invasive drug delivery approach.
Ophthalmology Innovation Showcase 1 - Ocular Therapeutix
Ocular Therapeutix is developing sustained-release drug therapies for ophthalmic conditions to improve patient outcomes and compliance. Their lead product, DEXTENZA, is an intracanalicular insert delivering dexamethasone for up to 30 days after cataract surgery to reduce pain and inflammation. Phase 3 trials showed DEXTENZA was well-tolerated and effective in meeting primary efficacy endpoints. If approved, DEXTENZA could become the new standard of care by replacing complex topical drop regimens. The company is also developing sustained-release therapies for glaucoma and posterior segment diseases in collaboration with Regeneron.
Envisia Therapeutics
This document summarizes corporate milestones and pipeline for Envisia Therapeutics, a company developing ophthalmic drug delivery systems. Key points include:
- The company was formed in 2013 and has raised $25 million in funding.
- They are developing long-acting biodegradable formulations of travoprost (ENV515) for glaucoma and difluprednate (ENV905) for post-cataract inflammation. Clinical trials are underway.
- Their PRINT technology platform can produce particles from 100nm to 1000um and is being used to develop extended release formulations of small molecules and biologics for front and back of the eye diseases.
PanOptica
The document summarizes the development of an anti-VEGF eye drop called PAN-90806 being developed by PanOptica for the treatment of wet age-related macular degeneration and other retinal diseases. It describes positive preliminary results from a Phase 1/2 clinical trial in wet AMD patients showing biological activity with no systemic side effects. It also outlines plans to further study PAN-90806 using an advanced formulation in additional clinical trials for wet AMD and proliferative diabetic retinopathy. Developing an effective anti-VEGF eye drop could provide significant benefits over frequent eye injections.
Allegro
Luminate is a drug being developed by Allegro Ophthalmics to treat retinal diseases. It works through a novel anti-integrin mechanism of action compared to existing anti-VEGF drugs. Phase 2 studies showed Luminate had a 65% efficacy rate in resolving vitreomacular traction, a robust safety profile, and durability of at least 3 months in treating diabetic macular edema and wet age-related macular degeneration. Ongoing phase 2b studies are further evaluating Luminate's potential to treat diabetic macular edema, proliferative vitreoretinopathy, and as an alternative to anti-VEGF drugs with longer duration of effect.
Acucela
Acucela is a clinical-stage ophthalmology company that develops novel therapeutics to treat sight-threatening eye diseases. Their lead product candidate, Emixustat hydrochloride, is being studied in clinical trials as a potential treatment for geographic atrophy associated with dry age-related macular degeneration. Preclinical studies showed Emixustat reduced the accumulation of toxins in the retina and protected retinal cells from light damage in a dose-dependent manner. Early clinical trials found Emixustat to be generally safe and well-tolerated, with pharmacologic effects observed in the retina. An ongoing Phase 2b/3 clinical trial is evaluating Emixustat's ability to reduce the growth rate of geographic
AGTC
This presentation discusses AGTC's visionary gene therapy programs to treat ophthalmic diseases. It highlights AGTC's lead product candidates for X-linked Retinoschisis (XLRS), Achromatopsia (ACHM-B3 and A3), and X-linked Retinitis Pigmentosa (XLRP). It also summarizes AGTC's competitive advantages in gene therapy manufacturing and its key upcoming milestones, including filing INDs for ACHM-A3 and XLRP and reporting initial clinical data for XLRS and ACHM-B3 programs in 2016. AGTC aims to become the world leader in ophthalmology gene therapy through its broad pipeline and partnerships.
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
This document provides an overview of a company called Aerie Pharmaceuticals and their glaucoma products. It summarizes results from clinical trials of their two leading investigational drug candidates, Rhopressa and Roclatan. Rhopressa achieved non-inferiority compared to timolol in lowering eye pressure over 6 months in phase 3 trials. A pilot study also found Rhopressa to be effective at lowering pressure during nighttime hours. Roclatan was found to be statistically superior to its individual components, latanoprost and Rhopressa, in lowering pressure at all timepoints in a phase 3 trial. Both drugs demonstrated favorable safety profiles in clinical testing.
Alcon Google Innovation
1) Alcon and Google have partnered to develop "smart lens" technology to address unmet medical needs in eye care, such as treating cataracts, age-related macular degeneration, glaucoma, and presbyopia.
2) The collaboration aims to create glucose-sensing contact lenses to help diabetics manage their condition, and accommodating contact lenses or IOLs to restore near vision for presbyopes.
3) While smart lenses offer advantages like ease of use and data sharing, challenges include ensuring patient privacy as health data is collected and regulatory hurdles in approving new mobile medical devices.
Aerie
Aerie Pharmaceuticals is developing Rhopressa and Roclatan as once-daily eye drops to lower intraocular pressure for glaucoma. Rhopressa demonstrated efficacy in Phase 3 trials and Aerie expects to file an NDA in Q3 2016. Roclatan achieved all endpoints in a Phase 2b trial and is now in Phase 3 trials. Preclinical research also shows Rhopressa may modify diseased tissue and increase blood flow in the eye. Aerie is exploring AR-13154 for wet AMD which showed lesion size reduction exceeding the leading product in studies. The company collaborates with other organizations on delivery technologies and product candidates for the front and back of the eye.
Workplace Health by Dr Jeremy Lim
Dr Jeremy Lim from Oliver Wyman shares key insights on implementing effective workplace health initiatives.
Case Study: SKF Battles Rising Health Care Costs with Walking Program
SKF USA Inc. implemented an integrated wellness program combining biometric screenings and a walking program to improve employee health and reduce rising healthcare costs. Over 80% of employees signed up for the program, which uses pedometers and an online portal to track steps and health goals. Participation remains over 60%, and SKF saw their annual health insurance rate increases drop from 11.3% to just 1.4% after implementing the program. Employees reported feeling healthier, more productive, and more positive about their employer as a result of the wellness initiative. Due to its success, SKF is looking to expand the program to other global entities.
Chris Adams (Ceeable): Augmented Reality to Treat Low Vision Disorders
A talk from the Life Track at AWE USA 2017 - the largest conference for AR+VR in Santa Clara, California May 31- June 2, 2017.
Chris Adams (Ceeable): Augmented Reality to Treat Low Vision Disorders
Ceeable is developing a mobile augmented reality (AR) device to aid people with low vision disorders such as age related macular degeneration (AMD), diabetic retinopathy and retinitis pigmentosum. There are over 280 million people worldwide who have vision disorders and over 15 million in the united states who have AMD. The Ceeable device is based on a commercially available AR hardware platform and incorporates proprietary and patented software algorithms to map and correct for visual distortions in real time. The technology has been demonstrated to be effective in clinical studies and the results have been published in peer review journals. The company envisions the device as the first of many products that will be a significant advancement in technologies to aid low vision patients and demonstrate the capability of AR to change the human condition.
http://AugmentedWorldExpo.com
What to Expect after LASIK
LASIK is an extremely safe and effective procedure that can help you eliminate the need for glasses and contacts. Find out what to expect during your recovery after surgery.
Aerie Pharmaceuticals
Aerie Pharmaceutics "Building a Major Ophthalmic Pharmaceutical Company" Presented at OIS@ASCRS 2015
StatArb Performance
This document summarizes the performance of a statistical arbitrage fund (StatArb1) compared to the S&P 500 index from inception on March 30, 2012 through May 2, 2012. It shows that StatArb1 has lower returns than the S&P 500 since inception and month-to-date, but lower volatility, beta, and maximum drawdown, indicating it may be a less risky investment.
Stat Arb Performance
This document summarizes the performance of a statistical arbitrage strategy compared to the S&P 500 from inception on March 30, 2012 through April 30, 2012. The statistical arbitrage strategy has outperformed the S&P 500 over all time periods shown with lower volatility, beta, and maximum drawdown, though it has a positive correlation to the S&P 500.
Graybug
GrayBug is developing an injectable, long-acting ocular drug delivery technology called GB-102 for treating wet age-related macular degeneration. GB-102 is a dual anti-VEGF/anti-PDGF therapeutic that enables injections every 4-6 months, compared to monthly injections currently required. GrayBug has worldwide rights to the technology from Johns Hopkins University and aims to file an IND for GB-102 in wet AMD in 2016. The company is also exploring applications of its technology for glaucoma and other ocular diseases, with the goal of developing long-acting drugs that improve compliance over daily eye drops.
What's hot (20)
Ophthalmology Innovation Showcase 1 - Ocular Therapeutix
Ophthalmology Innovation Showcase 1 - Ocular Therapeutix
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
Case Study: SKF Battles Rising Health Care Costs with Walking Program
Case Study: SKF Battles Rising Health Care Costs with Walking Program
Chris Adams (Ceeable): Augmented Reality to Treat Low Vision Disorders
Chris Adams (Ceeable): Augmented Reality to Treat Low Vision Disorders
Viewers also liked
Medically necessary contacts
This document provides information on medically necessary contact lenses including definitions, benefits, insurance plans, eligibility criteria, billing codes, and examples of how to determine diagnoses and appropriate billing for patients. It discusses criteria for medical necessity including conditions like keratoconus, irregular astigmatism, corneal disorders and transplants, and high ammetropia. Examples are provided of patients' exams and determining appropriate diagnoses and billing codes to use for medical insurance and vision plans. Reimbursement rates for different contact lens types and replacement schedules are also included.
Eye med summary
The document announces that effective January 1, 2013, vision plan benefits for railroad employees will be provided by EyeMed Vision Care instead of VSP. There will be no changes to plan design but some enhancements, including a larger provider network, ID cards for members, and increased discounts. Retirees will have access to a discount plan through EyeMed providers. In November, employees will receive information about the transition to EyeMed, and in January they will receive ID cards and details on their EyeMed benefits and providers.
My Vision Express Brochure 2015
This document discusses My Vision Express, an electronic health record and practice management system used by over 12,000 eye care professionals worldwide. It is used by both small single-person practices and large retail chains with hundreds of locations. Key features of My Vision Express include patient management, insurance processing, inventory management, electronic health records, and a patient portal. The system aims to streamline workflows and improve efficiency for eye care practices.
Insertar imagenes
El documento habla sobre la gran cantidad de basura que se encuentra en las montañas y parajes naturales debido a los domingueros que realizan excursiones en vehículo y dejan sus desperdicios atrás. A pesar de llegar en coche, lo que les facilitaría recoger la basura, muchos la dejan tirada creyendo erróneamente que al esconderla ensucian menos. El documento pide a todos ser más cívicos y no dejar huella de contaminación en la naturaleza.
Viñatas con imagenes
Los periféricos de entrada como teclado, ratón y micrófono permiten introducir datos al sistema, mientras que los periféricos de salida como monitor, impresora y altavoces permiten mostrar u obtener la salida de datos. Algunos periféricos como módem y multifunción permiten tanto la entrada como la salida de datos. Los sistemas de almacenamiento como discos duros, disquetes y CD-ROM/DVD-ROM almacenan datos de forma permanente o temporal.
BlackRock team paper
BlackRock is the largest asset management firm globally, managing over $4.77 trillion in assets. It offers a wide range of products including mutual funds, ETFs, and advisory services. BlackRock has a history of acquisitions that have expanded its capabilities. It faces competition from other large asset managers but maintains strength in its brand, scale, and risk management platform called Aladdin. Both opportunities in emerging markets and threats from regulation and economic downturns could impact BlackRock's future performance.
Azaperol.paper
This method confirms the presence of the tranquilizer azaperone and its metabolite azaperol in swine liver tissue using gas chromatography/mass spectrometry (GC/MS). Swine liver is ground and extracted using acetonitrile and sodium chloride buffer. Solid phase extraction is used to isolate azaperone and azaperol, which are then eluted and analyzed by GC/MS. The method was validated by analyzing fortified tissue samples containing 10 ppb of both compounds and incurred tissue from pigs dosed with azaperone, confirming the presence of the parent drug and metabolite.
Luxottica company
Luxottica is an Italian eyewear company founded in 1961 that designs, manufactures, and distributes eyewear. It has production facilities in Italy, China, Brazil, and the US and operates over 7,000 stores worldwide. In 2014, Luxottica produced 83 million pairs of prescription frames and sunglasses. While Luxottica is a market leader, its analysis shows it needs to improve asset turnover to generate more sales and use assets more efficiently.
Visual basic
El documento describe los controles comunes de Visual Basic, incluyendo etiquetas, cuadros de texto y botones de comando. Detalla las propiedades, eventos y métodos asociados con el control de etiqueta, que permite mostrar texto estático. También presenta un ejemplo de cómo cambiar los estilos de fuente de una etiqueta en respuesta a eventos de botón.
Points To Take Care Of Your Eyes
This document provides tips for eye health and protecting vision. It recommends sitting farther from computer screens to avoid eye strain from lights. Taking regular breaks to blink more and adjusting screen colors can help. Seeing an optician regularly for checkups and treatments is also suggested, as is wearing UV-protected glasses, eating a vitamin-rich diet, avoiding smoking, and drinking alcohol in moderation.
WinObjC: Windows Bridge para iOS
¿Tienes una aplicación iOS?, ¿quieres reaprovechar tus conocimientos y código Objective-C para acceder a la plataforma universal Windows?. En esta sesión conoceremos el Bridge de Windows para iOS, convertiremos algunas aplicaciones iOS a UWP e incluso veremos como añadir características específicas de la plataforma Windows como el uso de Live Tiles por ejemplo.
Extendiendo Xamarin.Forms
Xamarin.Forms es un framework que nos añade una capa de abstracción permitiendo desarrollar la interfaz de nuestras aplicaciones móviles multiplataforma una única vez, compartiendo el código de la UI. Veremos como crear aplicaciones con Xamarin.Forms además de centrarnos en cómo acceder a características propias de cada plataforma mediante la creación de servicios o Custom Renders.
Adaptando Apps Xamarin.Forms a tabletas
En esta sesión veremos como adaptar nuestras aplicaciones para otorgar la mejor experiencia posible en teléfonos y tabletas. Como adaptar vistas, tener vistas específicas, adaptar navegación o detectar DPIs y tamaño de pantalla serán algunos de los puntos que veremos.
Building Your Own IoT Platform using FIWARE GEis
Building Your Own IoT Platform using FIWARE GEis, by Jose Manuel Cantera Fonseca.
How-to session. 1st FIWARE Summit, Málaga, Dec. 13-15, 2016.
Denodo DataFest 2016: Enterprise View of Data with Semantic Data Layer
Watch the full session: Denodo DataFest 2016 sessions: https://goo.gl/kPmzWU
Gaining an enterprise view of the data across different independent lines of businesses is difficult when the operations, systems, and data are inherently siloed. VSP Global is a conglomerate operating different businesses across eyewear insurance, manufacturing, and retail. They are integrating the silos using a semantic data layer.
In this presentation, the Enterprise Data Architect at VSP Global, Tim Fredricks will present:
• The challenges associated with data siloed across different LOBs
• How to build a semantic data layer using data virtualization
• Centralizing business rules in the data virtualization layer
This session also includes a panel discussion with:
• Tim Fredricks, Enterprise Data Architect at VSP Global
• Rick Hart, Director of Global Technology Solutions at BioStorage Technologies
• Jeff Veis, VP Big Data Platform Marketing at HPE
• Mike Litzkow, Sales Director at Denodo (as moderator)
This session is part of the Denodo DataFest 2016 event. You can also watch more Denodo DataFest sessions on demand here: https://goo.gl/VXb6M6
This session is part of the Denodo DataFest 2016 event. You can also watch more Denodo DataFest sessions on demand here: https://goo.gl/VXb6M6
Xamarin Dev Days Madrid - Taller Xamarin
El documento describe un taller sobre el desarrollo de aplicaciones móviles con Xamarin. En el taller, los participantes crearán una aplicación meteorológica con información real utilizando conceptos como la estructura del proyecto, MVVM, diseño de interfaces y navegación. El taller se llevará a cabo de forma gradual a lo largo de 2,5 horas con explicaciones sobre Xamarin y demostraciones prácticas de cada parte de la aplicación.
Viewers also liked (16)
Denodo DataFest 2016: Enterprise View of Data with Semantic Data Layer
Denodo DataFest 2016: Enterprise View of Data with Semantic Data Layer
Similar to Jeremy Chadwick , VSP Vision Care
Diabetic eye disease
Over 112,000 people in Indiana have diabetic retinopathy, which is around 20% of diabetics in the state. About 60% of diabetics receive an annual eye exam, but each year between 12,000 to 24,000 new cases of blindness occur from diabetic retinopathy. Diabetic retinopathy is caused by changes in the blood vessels in the eye and can be detected and treated through annual dilated eye exams and procedures like laser surgery. Maintaining good control of blood sugar and receiving regular eye exams can help reduce the risk of vision loss from diabetic eye disease.
Core story10 12-13
Master Eye Associates commissioned a research study to investigate the link between health, wealth, and happiness. The study found that neglecting one's vision can negatively impact quality of life, career, and income. Poor vision is linked to lower job performance, higher rates of depression and anxiety, and increased risk of irreversible vision loss from conditions like glaucoma and macular degeneration. The study recommends comprehensive eye exams and choosing the most attractive vision correction option like contacts or LASIK to protect one's vision and maximize career, attractiveness, and overall well-being.
4 Alarming Ways That Neglecting Your Eyes Can Impact Your Health, Wealth & Ha...
Master Eye Associates commissioned a research study to investigate the link between health, wealth, and happiness. The study found that neglecting one's eyes can negatively impact quality of life, career, and income in several ways. Poor vision leads to poor job performance and lower income potential due to decreased attractiveness. It can also cause depression and anxiety. Early detection of eye diseases is important as some major causes of blindness like glaucoma and macular degeneration have no symptoms in early stages, resulting in irreversible vision loss. Regular eye exams are recommended to monitor eye health and vision.
Part 1 fundus imaging – presentation for www.eyenirvaan.com
This document discusses the need for fundus imaging in Indian optometry clinics. It notes that over 75% of blindness in India is avoidable through direct management or early detection of conditions like glaucoma, diabetic retinopathy, and refractive errors. Fundus imaging allows optometrists to monitor these conditions over time by comparing new images to past images. It also provides a wider view of the fundus than direct ophthalmoscopy alone. Non-mydriatic cameras can image up to 40 degrees of the fundus within seconds without pupil dilation. The document emphasizes the growing threat of diabetic retinopathy, as India is projected to see a 72% increase in its diabetic population by 2030. Early detection of diabetic
General Optometry
An optometrist examines patients' eyes, diagnoses eye diseases and conditions, and helps manage eye health issues. They check vision, eye alignment and coordination, eye health, and may provide treatments like eyeglasses, contact lenses, or referrals to specialists. Regular eye exams are important throughout life to detect issues early and maintain healthy vision and eye health.
Dr Somdutt Prasad: Eye Donation Awareness
1) Diabetic retinopathy screening programs have led to a reduction in blindness from diabetic retinopathy in the UK for the first time in decades.
2) Laser therapy remains the standard treatment for non-center involving diabetic macular edema and edema not affecting vision, while anti-VEGF drugs are preferred for center-involving edema and vision loss.
3) Ranibizumab injections are recommended monthly for 3 visits then as needed based on stability of vision and OCT findings for 6-12 months. Follow-up intervals can then be extended to 2-4 months if stability is maintained.
4 Alarming ways that neglecting your eyes can impact your health, wealth and ...
This document discusses the importance of eye health and vision correction. It notes that neglecting one's eyes can negatively impact health, wealth, and happiness. Poor vision is linked to lower job and income potential due to impacts on attractiveness, job performance, and mental health. Several common eye diseases like glaucoma and macular degeneration that cause vision loss often have no early symptoms and can lead to permanent blindness if not addressed. The document presents vision correction options like glasses, contacts, and LASIK as solutions and notes benefits like increased attractiveness and quality of life.
Sight first anup zimba
This document outlines Operation Eyesight's South Asia Programme Strategy from 2018 to 2022. The strategic goal is to eliminate avoidable blindness among vulnerable populations in India, Nepal, Bangladesh, Sri Lanka and Maldives by 2022. The strategy has four themes: 1) strengthening community eye health, 2) improving hospital facilities, 3) controlling diseases causing blindness, and 4) advocating for eye health. Key activities include training health workers, establishing vision centers, screening for conditions like diabetes, and performing surgeries. The strategy aims to impact over 30 million people across the region by 2022.
Alcon Corporate Presentation - short edition Sept 2016
The document discusses Alcon's mission to discover new ways to enhance sight and improve people's lives. It notes that hundreds of millions of people worldwide are affected by eye diseases but that scientific and technological innovation is improving outcomes. Alcon operates in 74 countries and serves patients in over 140 countries, with a workforce of 16,000 people from 96 nationalities working to advance eye care.
Dr Somdutt Prasad On Diabetes & Blindness: An overview & key to overcome
This document discusses strategies for preventing blindness from diabetes. It notes that diabetes affects over 171 million people worldwide. Screening for diabetic retinopathy is important using techniques like retinal photography that are acceptable and have high sensitivity and specificity. Nationwide screening programs in countries like the UK have helped reduce blindness from diabetic retinopathy and maculopathy as the leading cause of blindness in working age adults. Treatment options discussed include laser therapy, anti-VEGF injections like ranibizumab, vitrectomy, and intravitreal steroids. Regular screening and treatment when needed can effectively reduce vision loss from this condition.
Shared Wellness Clinics
Cooper Johnson: SVP Employee Benefits, S.S. Nesbitt & Co.
Presenting: Shared Wellness Clinics
Cooper is a student of employee benefits. Having spent his entire career consulting in this space, he has also worked at the forefront of moving S.S. Nesbitt & Co’s benefits practice from a brokerage-only focus in the early 2000s to a post-ACA, “beyond benefits” and holistic health plan design consulting practice.
Take care of your eyes
Caring your Eyes is More Important. Care Your Eyes with Proper Professional Guidance and Take Best Treatment by Consulting your Doctor.
REFRACTIVE ERROR AND LOW VISION AS PUBLIC HEALTH ISSUES
This document discusses refractive error as a major public health issue and cause of blindness and visual impairment globally. It notes that the WHO did not previously consider uncorrected refractive error an important cause, but studies showed it accounts for up to 25% of blindness and over 50% of visual impairment. Refractive error was added to the priority list of preventable blindness causes in 1999. The document outlines definitions and prevalence estimates of refractive error conditions. It emphasizes the need for affordable, accessible refractive services and discusses challenges and strategies to address uncorrected refractive error as a public health problem.
press release 2016
VSP Vision Care, the largest vision benefits provider in the US, announced a new health and wellness savings program called VSP Simple Values for its 75 million members. The program provides discounts on prescription drugs, diabetic supplies, telehealth services, travel, and entertainment. The goal is to deliver more value to members for their overall wellbeing, not just eye care. Members can access discounts by logging into their VSP account. The program was created through a partnership with Competitive Health, which delivers healthcare discount programs.
Steve Morton, Dan Cassell, Helen Hayes & Nicholas Gili
The Oldham Urgent Care Alliance was formed to transform urgent care in Oldham according to the NHS Five Year Plan. It has achieved a 5.8% reduction in unplanned hospital admissions through deflection projects and redesigning care pathways. Key achievements include establishing an integrated discharge team, an ambulatory care service, and a new model of pediatric urgent care. Moving forward, the Alliance plans to further develop front-end urgent care services and intermediate care, and improve readmission rates through continued collaboration between partners. The benefits to commissioners include improved coordination, resilience planning, intelligence gathering, and ultimately better outcomes for patients.
Getting People to Act
In this webinar, you will learn:
How we approach intervention campaigns: a framework
The science of behavior change and how it can be applied to increase the probability of desired outcomes
How Altarum’s ACE Measure can help predict consumer behaviors and design successful intervention campaigns
Speakers:
Ryan Rossier, Medullan
Chris Duke, Altarum
Josh Klapow, ChipRewards
Workplace mental health in England, Ireland and Sweden – a comparative study ...
Workplace mental health in England, Ireland and Sweden – a comparative study ...enterpriseresearchcentre
This document summarizes findings from a comparative study of workplace mental health in England, Ireland, and Sweden. It finds significant country-level differences in patterns of mental health-related sickness absence, presenteeism, engagement in mental health initiatives, and adoption of hybrid working models. Swedish firms reported lower impacts of mental health issues on operations despite higher absence rates. They were also more likely to invest in strategic initiatives than training. The implications discussed include how employers can best manage psychological detachment with remote working and address presenteeism issues that may arise.Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...Alvina Pauline Santiago, MD
A lay forum lecture about digital eye strain, dry eye disease in children, myopia and stopping myopia, other refractive errors, common causes of eye consults, some eye myths, the truth about blue light filter in glasses, and a little bit about presbyopia and cataract for parents of Xavier School Nuvali, July 31, 2022Arvind eye care hospital
Offer quality eye care at reasonable cost.
Provide services to rich and poor alike.
Financially self supporting.
Eradication of eye diseases.
Diabetes and your eyes
This document discusses diabetes and its effects on the eyes. It provides information on the three main types of diabetes, potential eye complications of diabetes including fluctuating vision, cataracts, glaucoma, and diabetic retinopathy. It describes treatments for diabetic retinopathy including laser photocoagulation and vitrectomy surgery. It stresses the importance of early detection through regular eye exams to prevent vision loss from diabetic retinopathy.
Similar to Jeremy Chadwick , VSP Vision Care (20)
4 Alarming Ways That Neglecting Your Eyes Can Impact Your Health, Wealth & Ha...
4 Alarming Ways That Neglecting Your Eyes Can Impact Your Health, Wealth & Ha...
Part 1 fundus imaging – presentation for www.eyenirvaan.com
Part 1 fundus imaging – presentation for www.eyenirvaan.com
4 Alarming ways that neglecting your eyes can impact your health, wealth and ...
4 Alarming ways that neglecting your eyes can impact your health, wealth and ...
Alcon Corporate Presentation - short edition Sept 2016
Alcon Corporate Presentation - short edition Sept 2016
Dr Somdutt Prasad On Diabetes & Blindness: An overview & key to overcome
Dr Somdutt Prasad On Diabetes & Blindness: An overview & key to overcome
REFRACTIVE ERROR AND LOW VISION AS PUBLIC HEALTH ISSUES
REFRACTIVE ERROR AND LOW VISION AS PUBLIC HEALTH ISSUES
Steve Morton, Dan Cassell, Helen Hayes & Nicholas Gili
Steve Morton, Dan Cassell, Helen Hayes & Nicholas Gili
Workplace mental health in England, Ireland and Sweden – a comparative study ...
Workplace mental health in England, Ireland and Sweden – a comparative study ...
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
Beyond the screen: caring for our eyes: 2022 kids pandemic eyes for XS Nuvali...
More from Investnet
Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn was diagnosed with diabetes in 1993 and began her journey of diabetes education and peer support that empowered her as a patient. She became involved in diabetes advocacy as a blogger, event organizer, and support group facilitator. Through education, family and peer support online and in support groups, she felt empowered in managing her diabetes.
Dr Neil Black , Consultant Physician
This document outlines a modified diabetes care model called the Portsmouth Model or "Super Six." It describes the different patient populations and types of care provided at the hospital, primary care, and diabetes support team levels. The hospital team focuses on acute, pregnancy/pre-pregnancy, active foot disease, advancing CKD/RRT, type 1 diabetes including insulin pumps, and complex type 2 diabetes patients. Primary care manages those at risk of diabetes, with controlled type 2 diabetes, and uncontrolled type 2 diabetes with guidelines. The diabetes support team cares for uncontrolled type 2 diabetes patients and type 1 patients who do not attend appointments are invited to an online community. Patient numbers are provided for each group.
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
This document summarizes a presentation on diabetes, atherosclerosis, and cholesterol. It discusses how diabetes increases the risk of cardiovascular disease and mortality. It notes that achieving lipid targets substantially reduces cardiovascular risk, but that target achievement is still uncommon. New therapies that inhibit microsomal triglyceride transfer protein, apolipoprotein C3, proprotein convertase subtilisin/kexin type 9, and other targets may help lower lipids and reduce risk, but require further study of long-term safety and efficacy. The need to more intensively reduce risk factors to further lower cardiovascular event rates is emphasized.
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Ronan Canavan, a consultant endocrinologist, gave a presentation at the Future Health Summit on designing better diabetes care. The presentation discussed standards, an integrated care model, retinopathy screening and treatment, podiatry, education, and paediatrics. It reviewed a 1999 model of diabetes care and discussed progress made in the last 5 years, including establishing a clinical diabetes program, retinal screening, developing a model of care for diabetic foot care, and integrated diabetes nurse specialists. The presentation concluded by discussing how Ireland can be the best in areas like prevention, technology, and education.
Healthbridge
This document presents information on CliniBridge, a behavioral analysis software platform for clinicians that is integrated with a mobile platform for patients and caregivers. The platforms were pilot tested with Sussex Community NHS Trust and aimed to 1) avoid patient relapses and readmissions to meet funding targets, 2) allow patients to self-manage for improved outcomes, 3) increase the effectiveness of therapy, and 4) use silent data and intervention systems. The platforms were presented by Dervilla O'Brien, Managing Director and Co-Founder of CliniBridge.
Malcolm R. Kell, Breast Cancer Survivor
The document describes an app developed by Dr. Malcolm R. Kell and colleagues to help breast cancer survivors focus on physical activity, diet, and reducing their body mass index (BMI) after treatment. The free app allows users to select an exercise intensity, see how much exercise is needed over 10 weeks to lower BMI by 10%, update their BMI, and access simple recipes to support a healthy diet for weight loss. The goal is to provide breast cancer survivors a simple tool to promote healthy living and improved survivorship after breast cancer.
Control Drink
Serious problems require serious solutions. Alcohol misuse costs €57 billion annually and only 1 in 9 people who misuse alcohol receive treatment. A smartphone and web-based platform is proposed as an innovative, user-friendly, evidence-based, and cheaper way to provide personalized treatment at scale. The platform utilizes computerized cognitive behavioral therapy and text messaging, which studies have shown can be effective in treating alcohol misuse. It seeks to revolutionize the UK addiction treatment market and plans clinical trials in Ireland and the UK in 2016 before rolling out more broadly in Europe and the US.
Robert Kelly, Videodoc
Dr. Robert Kelly discusses pressures facing the Irish health system including resources, costs, quality, and efficiency. Barriers include doctors' limited time and resources, and patients' issues with access, time, mobility and costs. Telemedicine can help overcome these barriers by giving patients more convenient lower-cost access supported by information to high-quality care. VideoDoc is an Irish telemedicine platform provider that operates a virtual clinic model and enables doctors to integrate the platform into their practices to develop telemedicine solutions for patients. The platform aims to improve healthcare experiences and outcomes at affordable costs through more engaged patients.
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
This document discusses the regulation of standalone software as a medical device. It begins by defining standalone software and noting the EU directive that amended the definition of a medical device to include software intended for medical purposes. It then covers how to qualify standalone software as a medical device and classify it. The document reviews essential requirements, harmonized standards, conformity assessment procedures including CE marking, and registration requirements. It provides advice for manufacturers on ensuring compliance and for users on reporting issues. The role of the Irish regulator HPRA in providing guidance and conducting oversight is also discussed.
Anastasia Dedyukhina , Consciously Digital
This document summarizes the effects of digital distraction on human behavior and brain function. It notes that people now spend 2-3 times as much time online as a decade ago and most check social media daily and switch between devices over 20 times an hour. This constant connectivity is changing how our brain functions, shortening attention spans and affecting memory. The ability to stay focused without distraction has become a rare "superpower." However, the document also sees opportunities to make sense of data and provide tips to use technology in a supportive rather than substitutive way.
Sasha Oliver, Avloni
1) The document discusses using neuroimaging and machine learning to detect dementia earlier by predicting which patients with mild cognitive impairment (MCI) will progress to dementia within a year.
2) The researchers have developed a model that can predict MCI to dementia progression with 75% accuracy by analyzing brain MRIs.
3) They are working to improve their model's accuracy and to predict the biological brain age and time to dementia for patients.
Jemma Gatliff, Keregen
Keregen Therapeutics is a UK-based early stage drug discovery and development company focused on developing precision medicines for Parkinson's Disease. They were founded in 2015 and are operating out of University College London and Stevenage Bioscience Catalyst. Keregen is developing first-in-class small molecule activators of the Nrf2 pathway as a disease-modifying treatment for Parkinson's with the goal of a safer oral therapy that can be taken once daily. The company has participated in accelerator programs, secured initial funding, hired new employees, and aligned with academia to access resources and personnel as they progress their lead candidate towards clinical trials.
Darren Cunningham, Inflection Bio Sciences
Darren Cunningham, CEO of Inflection Bio, presented an overview of the company's mission to develop new cancer treatments by targeting the PIM kinase pathway. Inflection Bio has a pipeline of targeted therapeutics for cancers like multiple myeloma, NSCLC, and hematological malignancies. Its lead candidates inhibit both PIM and PI3K/mTOR to address resistance to existing therapies. The company utilizes a network of research collaborators and has raised €2.2 million to advance its preclinical programs, with the goal of securing partners after Phase I trials.
Phision Theraputics
This document discusses developing more effective drug delivery systems for treating blindness linked to diabetes or aging. It describes Phision Therapeutics' work on developing novel small molecule drugs and biodegradable microcapsule formulations for sustained drug release over 4-6 months via microneedles, as an alternative to frequent eye injections. The founders aim to commercialize this technology to reduce the burden of treatment for patients and clinicians.
Niamh Malone , Brainey App
This document describes the development of the BraineyApp, a mobile application created by Niamh Malone to help with self-recovery and rehabilitation following acquired brain injuries like stroke or traumatic brain injury. The app provides a personalized recovery journey broken into weekly and monthly goals. It underwent user testing and focus groups. Funding is being sought to further develop prototypes with input from medical experts and technology companies to expand the app's reach and features to support recovery from various neurological conditions and surgeries.
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Evadiagnostics provides a smart health solution that offers immediate blood testing and actionable patient information to help with triaging. Their clinically validated platform technology connects devices, software, and data to improve patient care through better planning and quality of care driven by new data insights. They were recently recognized as European winners for their award-winning team and significant health economic impact through health solutions that improve patient outcomes.
Ena Prosser, Fountain Healthcare Partners
This document summarizes information about a life sciences venture capital partnership. They have €170 million under management across two funds and invest in companies seeking €8-10 million or more that have large market potential and an acceptable level of risk. Their team includes experts across clinical, commercial, IP, manufacturing and legal areas. They take an active role in their investments and want to connect early with companies that have strong teams critical to success.
Cathal Friel, Raglan Capital
Raglan Capital is an investment firm based in Dublin that develops investment opportunities by identifying and sourcing proprietary projects. In recent years it has raised over $500 million for ventures in sectors like oil and gas, financial technology, online gaming, medtech, and life sciences. One of Raglan's recent successes was instrumental in the formation of Amryt Pharma, a rare disease drug company that listed on the London AIM exchange in April 2016 with a market capitalization of $50 million and $20 million in cash.
Kieran O’Connell , DIT Hothouse
Academic institutions in Ireland are driving support and innovation in several ways:
1) Through technology transfer offices and innovation centers that work directly with industry to identify needs and fund applied research projects to develop solutions.
2) By establishing research centers organized around key industry sectors like food and agriculture that are jointly funded and driven by partnerships between academia and industry.
3) By offering degree programs, facilities, expertise and other resources to support industry-identified priorities and challenges in areas like biomedical technologies and brewing/distilling.
More from Investnet (20)
Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Recently uploaded
Mental Health and Physical Wellbeing.pdf
Mental Health and well-being Presentation. Exploring innovative approaches and strategies for enhancing mental well-being. Discover cutting-edge research, effective strategies, and practical methods for fostering mental well-being.
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital India will need a big trained army of Health Informatics educated & trained manpower in India.
Presently, generalist IT manpower does most of the work in the healthcare industry in India. Academic Health Informatics education is not readily available at school & health university level or IT education institutions in India.
We look into the evolution of health informatics and its applications in the healthcare industry.
HIMMS TIGER resources are available to assist Health Informatics education.
Indian Health universities, IT Education institutions, and the healthcare industry must proactively collaborate to start health informatics courses on a big scale. An advocacy push from various stakeholders is also needed for this goal.
Health informatics has huge employment potential and provides a big business opportunity for the healthcare industry. A big pool of trained health informatics manpower can lead to product & service innovations on a global scale in India.
The Importance of Black Women Understanding the Chemicals in Their Personal C...
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
Sectional dentures for microstomia patients.pptx
Microstomia, characterized by an abnormally small oral aperture, presents significant challenges in prosthodontic treatment, including limited access for examination, difficulties in impression making, and challenges with prosthesis insertion and removal. To manage these issues, customized impression techniques using sectional trays and elastomeric materials are employed. Prostheses may be designed in segments or with flexible materials to facilitate handling. Minimally invasive procedures and the use of digital technologies can enhance patient comfort. Education and training for patients on prosthesis care and maintenance are crucial for compliance. Regular follow-up and a multidisciplinary approach, involving collaboration with other specialists, ensure comprehensive care and improved quality of life for microstomia patients.
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
At Malayali Kerala Spa Ajman, Full Service includes individualized care for every client. We specifically design each massage session for the individual needs of the client. Our therapists are always willing to adjust the treatments based on the client's instruction and feedback. This guarantees that every client receives the treatment they expect.
By offering a variety of massage services, our Ajman Spa Massage Center can tackle physical, mental, and emotional illnesses. In addition, efficient identification of specific health conditions and designing treatment plans accordingly can significantly enhance the quality of massaging.
At Malayali Kerala Spa Ajman, we firmly believe that everyone should have the option to experience top-quality massage services regularly. To achieve that goal we offer cheap massage services in Ajman.
If you are interested in experiencing transformative massage treatment at Malayali Kerala Spa Ajman, you can use our Ajman Massage Center WhatsApp Number to schedule your next massage session.
Contact @ +971 529818279
Visit @ https://malayalikeralaspaajman.com/
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
Here are some key objectives of communication with children:
Build Trust and Security:
Establish a safe and supportive environment where children feel comfortable expressing themselves.
Encourage Expression:
Enable children to articulate their thoughts, feelings, and experiences.
Promote Emotional Understanding:
Help children identify and understand their own emotions and the emotions of others.
Enhance Listening Skills:
Develop children’s ability to listen attentively and respond appropriately.
Foster Positive Relationships:
Strengthen the bond between children and caregivers, peers, and other adults.
Support Learning and Development:
Aid cognitive and language development through engaging and meaningful conversations.
Teach Social Skills:
Encourage polite, respectful, and empathetic interactions with others.
Resolve Conflicts:
Provide tools and guidance for children to handle disagreements constructively.
Encourage Independence:
Support children in making decisions and solving problems on their own.
Provide Reassurance and Comfort:
Offer comfort and understanding during times of distress or uncertainty.
Reinforce Positive Behavior:
Acknowledge and encourage positive actions and behaviors.
Guide and Educate:
Offer clear instructions and explanations to help children understand expectations and learn new concepts.
By focusing on these objectives, communication with children can be both effective and nurturing, supporting their overall growth and well-being.
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
UoA毕业证学历书【微信95270640】办文凭{昆士兰科技大学毕业证}Q微Q微信95270640UoA毕业证书成绩单/学历认证UoA Diploma未毕业、挂科怎么办？+QQ微信：Q微信95270640-大学Offer（申请大学）、成绩单（申请考研）、语言证书、在读证明、使馆公证、办真实留信网认证、真实大使馆认证、学历认证
办理国外昆士兰科技大学毕业证书 #成绩单改成绩 #教育部学历学位认证 #毕业证认证 #留服认证 #使馆认证（留学回国人员证明） #（证）等
真实教育部认证教育部存档中国教育部留学服务中心认证（即教育部留服认证）网站100%可查.
真实使馆认证（即留学人员回国证明）使馆存档可通过大使馆查询确认.
留信网认证国家专业人才认证中心颁发入库证书留信网永久存档可查.
昆士兰科技大学昆士兰科技大学毕业证文凭证书毕业证 #成绩单等全套材料从防伪到印刷从水印到钢印烫金跟学校原版100%相同.
国际留学归国服务中心：实体公司注册经营行业标杆精益求精！
国外毕业证学位证成绩单办理流程：
1客户提供办理昆士兰科技大学昆士兰科技大学毕业证文凭证书信息：姓名生日专业学位毕业时间等（如信息不确定可以咨询顾问：我们有专业老师帮你查询）；
2开始安排制作昆士兰科技大学毕业证成绩单电子图；
3昆士兰科技大学毕业证成绩单电子版做好以后发送给您确认；
4昆士兰科技大学毕业证成绩单电子版您确认信息无误之后安排制作成品；
5昆士兰科技大学成品做好拍照或者视频给您确认；
6快递给客户（国内顺丰国外DHLUPS等快递邮寄昆士兰科技大学昆士兰科技大学毕业证文凭证书）。闷不乐的样子父亲特意带山娃去找三楼房东家的儿子小伍玩小伍比山娃小一岁虎头虎脑的很霸气父亲让山娃跟小伍去夏令营听课山娃很高兴夏令营就设在附近一所小学山娃发现那所小学比自己的学校更大更美操场上还铺有塑胶跑道呢里面很多小朋友一班一班的快快乐乐原来城里娃都藏这儿来了怪不得平时见不到他们山娃恍然大悟起来吹拉弹唱琴棋书画山娃都不懂却什么都想学山娃怨自己太笨什么都不会斟酌再三山娃终于选定了学美术当听说每月要交感
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
EUR毕业证offer【微信95270640】《鹿特丹伊拉斯姆斯大学毕业证书原版制作EUR成绩单》【Q微信95270640】《仿制EUR毕业证成绩单鹿特丹伊拉斯姆斯大学学位证书pdf电子图》，A.为什么留学生需要操作留信认证?
留信认证全称全国留学生信息服务网认证,隶属于北京中科院。①留信认证门槛条件更低,费用更美丽,并且包过,完单周期短,效率高②留信认证虽然不能去国企,但是一般的公司都没有问题,因为国内很多公司连基本的留学生学历认证都不了解。这对于留学生来说,这就比自己光拿一个证书更有说服力,因为留学学历可以在留信网站上进行查询!
B.为什么我们提供的毕业证成绩单具有使用价值？
查询留服认证是国内鉴别留学生海外学历的唯一途径，但认证只是个体行为，不是所有留学生都操作，所以没有办理认证的留学生的学历在国内也是查询不到的，他们也仅仅只有一张文凭。所以这时候我们提供的和学校颁发的一模一样的毕业证成绩单，就有了使用价值。
实体公司，专业可靠，办理加拿大毕业证|办美国成绩单|做德国文凭学历认证|办新西兰学位证，办澳洲文凭认证，办留信网认证（网上可查，实体公司，专业可靠）铸就十年品质！信誉！实体公司！
办理国外鹿特丹伊拉斯姆斯大学毕业证书 #成绩单改成绩 #教育部学历学位认证 #毕业证认证 #留服认证 #使馆认证（留学回国人员证明） #（证）等
真实教育部认证教育部存档中国教育部留学服务中心认证（即教育部留服认证）网站100%可查.
真实使馆认证（即留学人员回国证明）使馆存档可通过大使馆查询确认.
留信网认证国家专业人才认证中心颁发入库证书留信网永久存档可查.
鹿特丹伊拉斯姆斯大学鹿特丹伊拉斯姆斯大学毕业证假文凭毕业证 #成绩单等全套材料从防伪到印刷从水印到钢印烫金跟学校原版100%相同.
国际留学归国服务中心：实体公司注册经营行业标杆精益求精！
国外毕业证学位证成绩单办理流程：
1客户提供办理鹿特丹伊拉斯姆斯大学鹿特丹伊拉斯姆斯大学毕业证假文凭信息：姓名生日专业学位毕业时间等（如信息不确定可以咨询顾问：我们有专业老师帮你查询）；
2开始安排制作鹿特丹伊拉斯姆斯大学毕业证成绩单电子图；
3鹿特丹伊拉斯姆斯大学毕业证成绩单电子版做好以后发送给您确认；
4鹿特丹伊拉斯姆斯大学毕业证成绩单电子版您确认信息无误之后安排制作成品；
5鹿特丹伊拉斯姆斯大学成品做好拍照或者视频给您确认；
6快递给客户（国内顺丰国外DHLUPS等快递邮寄鹿特丹伊拉斯姆斯大学鹿特丹伊拉斯姆斯大学毕业证假文凭）。地跟着父亲昼夜兼程第二天凌晨就辗转到了父亲的城哇父亲的城真的好大好美哟走出广州火车东站的那一刻山娃感受到了一种从未有过的激动和震撼太美了可爱的广州父亲的城山娃惊喜得几乎叫出声来山娃觉得父亲太伟大了居然能单匹马地跑到这么远这么大这么美的地方赚大钱高楼大厦鳞次栉比大街小巷人潮涌动山娃一路张望一路惊叹他发现城里的桥居然层层叠叠扭来扭去桥下没水却有着水一般的车水马龙山娃惊诧于城里的公交车那么大那么美不的
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
End-tidal carbon dioxide (ETCO2) is the level of carbon dioxide that is released at the end of an exhaled breath. ETCO2 levels reflect the adequacy with which carbon dioxide (CO2) is carried in the blood back to the lungs and exhaled.
Non-invasive methods for ETCO2 measurement include capnometry and capnography. Capnometry provides a numerical value for ETCO2. In contrast, capnography delivers a more comprehensive measurement that is displayed in both graphical (waveform) and numerical form.
Sidestream devices can monitor both intubated and non-intubated patients, while mainstream devices are most often limited to intubated patients.
Hypertension and it's role of physiotherapy in it.
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
This edition features a handful of Innovative Minds: France's Most Impactful Healthcare Leaders that are leading us into a better future.
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
Air Ambulance Services In Rewa works in close coordination with ground-based emergency services, including local Emergency Medical Services, fire departments, and law enforcement agencies.
More@: https://tinyurl.com/2shrryhx
More@: https://tinyurl.com/5n8h3wp8
Pneumothorax and role of Physiotherapy in it.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Get Covid Testing at Fit to Fly PCR Test
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.www.nxhealthcare.co.uk
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Imagine AI making your pharmacy experience smoother, safer, and more personalized.
Recently uploaded (20)
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
The Importance of Black Women Understanding the Chemicals in Their Personal C...
The Importance of Black Women Understanding the Chemicals in Their Personal C...
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
Friendly Massage in Ajman - Malayali Kerala Spa Ajman
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
CHAPTER 1 SEMESTER V COMMUNICATION TECHNIQUES FOR CHILDREN.pdf
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Psychedelic Retreat Portugal - Escape to Lighthouse Retreats for an unforgett...
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Jeremy Chadwick , VSP Vision Care
- 1. VSP Proprietary & Confidential Vision Care : A Core Workplace Benefit 27 May 2016 Jeremy Chadwick, Managing Director EMEA
- 2. VSP Vision Care 34,000 network providers partner with VSP Vision Care 80 million VSP Vision Care members worldwide Largest not-for-profit vision benefits and services company We help people see by putting members first.
- 3. VSP Proprietary & Confidential Vision Is Important 63.4% 61.5% Of companies offer vision care with VSP to their employees
- 4. VSP Proprietary & Confidential The Human Eye: Complex Machinery
- 5. VSP Proprietary & Confidential Comprehensive Eyesight Exam • Visual Acuity • Refraction Test – Determines the amount of vision correction • Refractive Errors – Nearsighted, Farsighted, Astigmatism, Presbyopia • Visual System Evaluation – External exam, Internal exam and pupil dilation • Tonometry Test – “Puff test” measures the fluid pressure inside the eye • Digital Retinal Imagery [DRI] – photo of the back of the eye • OCT – [Optical Coherence Tomography] 3D slide through the eye
- 6. VSP Proprietary & Confidential Prescriptions Astigmatic Cornea’s surface is not spherical – creates a twisted image Presbyopic Diminished focusing as we age
- 7. VSP Proprietary & Confidential Vision Related Diseases Diabetic Retinopathy Macular Degeneration Glaucoma
- 8. VSP Proprietary & Confidential Eyesight Exam Outcomes Hypertension High Cholesterol Prescriptions Eye-specific conditions Diabetes
- 9. VSP Proprietary & Confidential Employee Health Poor diet Poor health screening Stress Lack of sleep Inactivity Smoking Excessive alcohol consumption Are linked to serious condition health risks Seven employee behaviours linked to employment Hypertension High cholesterol Chronic back pain Coronary heart disease Cancer Lung disease Kidney disease Diabetes Depression Arthritis
- 10. VSP Proprietary & Confidential Diabetes Growth and Impact - US UK and Ireland following this trend
- 11. VSP Proprietary & Confidential Diabetes - Ireland
- 12. VSP Proprietary & Confidential Cost Savings – US Case Study 0 Year 1 Year 2 Year 3 Year 4 Early detection of diabetes $2,246 Savings Savings increase to $2,787 Savings increase to $3,120
- 13. VSP Proprietary & Confidential Measuring the Value 145% ROI VSP Vision plans £420 Per employee saving • A five year independent study conducted by Human Capital Management Sevices identified a 145% ROI on VSP vision plans • Companies that target 3 major modifiable risk factors can save an average of £420/employee/year in health care costs and productivity improvements
- 14. VSP Proprietary & Confidential Better Business Through Smarter Vision Care Healthier employees, better condition identification and management Productivity improvement Return on Investment from employees and cost avoidance Employee engagement and retention , better benefit buying, wellness programme design
- 15. VSP Proprietary & Confidential Co-brand Option Discussion/Questions vsp-ireland.ie vsp-uk.co.uk
Editor's Notes
- VSP partners with over 34,000 doctors and 80 million members worldwide 75 million members in the US – nearly 1 in 5 U.S. residents, 5 million members in Australia, Canada, Ireland and the U.K. - VSP is the largest national not-for-profit vision benefits and services company, serving 54,500+ clients, including over half of Fortune 500 companies. - We’re not led by shareholders, so we can focus on helping people see by reinvesting money earned into the advancement of optometry and philanthropic programs in communities around the globe.
- 6 in 10 Fortune 100 companies offer VSP Fortune 500 statistics from July 2015 – 301 having VSP with 475 companies offering a vision plan Fortune 100 statistics from March 2015 – 56 having VSP with 92 companies offering a vision plan
- Top 15 chronic conditions account for 80pc of chronic disease costs worldwide